Registry of Acute Coronary Syndrome in the Regional Cardiovascular Center (STOCS)
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Moscow, Russia, 101990
- National Medical Research Centre for Therapy and Preventive Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Men and women aged 18 and over, permanently residing in the Moscow region and in Moscow.
- Patients hospitalized in the Regional Vascular Center of Stupino Clinical Hospital (GBUZ MO SKB) with a diagnosis of ACS with and without ST-segment elevation.
- Signing an informed consent form to participate in the study and the processing of personal data, as well as conducting a telephone survey during the follow-up.
Exclusion Criteria:
- The patient's refusal to participate in the study and to allow the use of personal data during the study.
- The presence of mental illness.
- The patient plans to leave Russia for permanent or long-term residence.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
No
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
all-cause mortality
Time Frame: 1 year and 3 years
|
1 year and 3 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Сombined secondary end-point
Time Frame: 1 year and 3 years
|
Rate of nonfatal myocardial infarction, nonfatal stroke, hospitalization for decompensated heart failure, and emergency invasive cardiac interventions.
|
1 year and 3 years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Sergey Martsevich, D.M., professor, National Medical Research Centre for Therapy and Preventive Medicine, Moscow, Russia
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 03-06/24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.